0000315066-22-001561.txt : 20220414 0000315066-22-001561.hdr.sgml : 20220414 20220414171302 ACCESSION NUMBER: 0000315066-22-001561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220412 FILED AS OF DATE: 20220414 DATE AS OF CHANGE: 20220414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39208 FILM NUMBER: 22828191 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beam Therapeutics Inc. CENTRAL INDEX KEY: 0001745999 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-327-8775 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-04-12 0 0001745999 Beam Therapeutics Inc. BEAM 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 1 1 See Remark 1 Common Stock 2022-04-12 4 J 0 978503 0 D 2935511 I F-Prime Capital Partners Healthcare Fund V LP Common Stock 2022-04-12 4 J 0 509490 0 A 509995 I Impresa Fund III Limited Partnership Common Stock 2022-04-12 4 J 0 509332 0 D 663 I Impresa Fund III Limited Partnership Common Stock 2022-04-12 4 J 0 137845 0 A 141151 I F-Prime Capital Partners Healthcare Advisors Fund V LP Common Stock 2022-04-12 4 J 0 128333 0 D 12818 I F-Prime Capital Partners Healthcare Advisors Fund V LP Common Stock 2022-04-12 4 J 0 15406 0 A 18803 I F-Prime Inc. Common Stock 2022-04-12 4 J 0 422120 0 A 2490515 I Shares held by persons and entities whose shares are subject to reporting by the undersigned. Common Stock 2022-04-13 4 S 0 663 50.75 D 0 I Impresa Fund III Limited Partnership Common Stock 2022-04-13 4 S 0 6799 50.7 D 12004 I F-Prime Inc. Common Stock 2022-04-13 4 S 0 8804 50.01 D 3200 I F-Prime Inc. Common Stock 2022-04-13 4 S 0 3200 50.8 D 0 I F-Prime Inc. These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $50.50 to $51.00. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $49.75 to $50.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund V LP is F-Prime Capital Partners Healthcare Advisors Fund V LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the general partner of its general partner and its investment manager. Impresa Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. F-Prime Inc. is a wholly-owned subsidiary of FMR LLC. Kevin M. Meagher, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson 2022-04-14